Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Abbott discovers novel nonpeptidic antagonists of LFA-1/ICAM-1 interaction

Aug. 24, 2000

FDA approves Azulfidine EN-tabs as treatment of juvenile RA

Aug. 24, 2000

Selective ICAM-1 and E-selectin inhibitors on human endothelial cells explored

Aug. 22, 2000

Kyowa Hakko claims new series of NF-kappaB inhibitors

Aug. 18, 2000

Etanercept is well tolerated and efficacious as psoriatic arthritis and psoriasis treatment

Aug. 11, 2000

Patent recently issued to Abbott covering MMP inhibitors and their use

Aug. 10, 2000

Gene found to regulate protein associated with immune system disorders

Aug. 10, 2000

Phase II study of clenoliximab in rheumatoid arthritis begins

Aug. 9, 2000

Suppression of mitochondrial respiration linked to osteoarthritis

Aug. 9, 2000

Cypress Bioscience expands Prosorba Column pilot program

Aug. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...